Consensus exists about the protective role of increased FT expression during experimental stroke, and the same applies to hepcidin in AIS; however, the role of blunting the ischemia-induced upregulation of Tf and TfR remains controversial. The gene discussed is TFRC; the disease is stroke disorder.